VANTA BIOSCIENCE | #_#removed-CROWN LIFTERS | VANTA BIOSCIENCE/ #_#removed-CROWN LIFTERS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 0.0 | - | View Chart |
P/BV | x | 2.2 | 0.0 | - | View Chart |
Dividend Yield | % | 0.0 | - | - |
VANTA BIOSCIENCE #_#removed-CROWN LIFTERS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
VANTA BIOSCIENCE Mar-23 |
#_#removed-CROWN LIFTERS Mar-23 |
VANTA BIOSCIENCE/ #_#removed-CROWN LIFTERS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 138 | NA | - | |
Low | Rs | 56 | NA | - | |
Sales per share (Unadj.) | Rs | 9.9 | 18.5 | 53.7% | |
Earnings per share (Unadj.) | Rs | -16.6 | 3.7 | -442.2% | |
Cash flow per share (Unadj.) | Rs | -12.3 | 6.3 | -196.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0.20 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 27.8 | 20.3 | 136.7% | |
Shares outstanding (eoy) | m | 6.31 | 10.41 | 60.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 9.7 | 0 | - | |
Avg P/E ratio | x | -5.8 | 0 | - | |
P/CF ratio (eoy) | x | -7.8 | 0 | - | |
Price / Book Value ratio | x | 3.5 | 0 | - | |
Dividend payout | % | 0 | 5.3 | -0.0% | |
Avg Mkt Cap | Rs m | 610 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 35 | 19 | 179.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 63 | 193 | 32.6% | |
Other income | Rs m | 7 | 4 | 162.8% | |
Total revenues | Rs m | 70 | 197 | 35.3% | |
Gross profit | Rs m | -24 | 55 | -43.7% | |
Depreciation | Rs m | 27 | 26 | 101.1% | |
Interest | Rs m | 59 | 2 | 3,164.5% | |
Profit before tax | Rs m | -103 | 31 | -334.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | -8 | -22.0% | |
Profit after tax | Rs m | -104 | 39 | -268.0% | |
Gross profit margin | % | -38.1 | 28.4 | -134.3% | |
Effective tax rate | % | -1.8 | -27.0 | 6.6% | |
Net profit margin | % | -166.4 | 20.2 | -823.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 152 | 193 | 79.1% | |
Current liabilities | Rs m | 177 | 79 | 225.4% | |
Net working cap to sales | % | -39.9 | 59.2 | -67.4% | |
Current ratio | x | 0.9 | 2.4 | 35.1% | |
Inventory Days | Days | 95 | 7 | 1,291.9% | |
Debtors Days | Days | 113,923 | 1,049,591 | 10.9% | |
Net fixed assets | Rs m | 695 | 208 | 334.3% | |
Share capital | Rs m | 63 | 104 | 60.6% | |
"Free" reserves | Rs m | 112 | 107 | 104.5% | |
Net worth | Rs m | 175 | 211 | 82.9% | |
Long term debt | Rs m | 471 | 86 | 544.2% | |
Total assets | Rs m | 847 | 401 | 211.5% | |
Interest coverage | x | -0.7 | 17.5 | -4.3% | |
Debt to equity ratio | x | 2.7 | 0.4 | 656.5% | |
Sales to assets ratio | x | 0.1 | 0.5 | 15.4% | |
Return on assets | % | -5.4 | 10.2 | -52.8% | |
Return on equity | % | -59.6 | 18.4 | -323.4% | |
Return on capital | % | -6.8 | 10.9 | -62.0% | |
Exports to sales | % | 34.3 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 22 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 22 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 22 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -6 | 108 | -5.8% | |
From Investments | Rs m | -59 | -84 | 70.6% | |
From Financial Activity | Rs m | 64 | 85 | 75.7% | |
Net Cashflow | Rs m | -1 | 109 | -1.2% |
Indian Promoters | % | 69.4 | 75.0 | 92.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 30.6 | 25.0 | 122.6% | |
Shareholders | 418 | 1,938 | 21.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare VANTA BIOSCIENCE With: EKI ENERGY SERVICES LATENT VIEW ANALYTICS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | VANTA BIOSCIENCE | #_#removed-CROWN LIFTERS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.83% | 0.00% | 0.97% |
1-Month | -8.67% | 0.00% | 2.08% |
1-Year | 17.72% | 0.00% | 55.37% |
3-Year CAGR | -28.90% | -100.00% | 15.04% |
5-Year CAGR | -20.44% | -100.00% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the VANTA BIOSCIENCE share price and the #_#removed-CROWN LIFTERS share price.
Moving on to shareholding structures...
The promoters of VANTA BIOSCIENCE hold a 69.4% stake in the company. In case of #_#removed-CROWN LIFTERS the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VANTA BIOSCIENCE and the shareholding pattern of #_#removed-CROWN LIFTERS.
Finally, a word on dividends...
In the most recent financial year, VANTA BIOSCIENCE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
#_#removed-CROWN LIFTERS paid Rs 0.2, and its dividend payout ratio stood at 5.3%.
You may visit here to review the dividend history of VANTA BIOSCIENCE, and the dividend history of #_#removed-CROWN LIFTERS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.